Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-01

Clinical Trial Update: Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management

View source ↗

Summary

An observational study sponsored by Proove Bioscience evaluating how genetic testing influences decision-making and care in interventional pain management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Proove Bioscience, Inc. | Conditions: Pain, Chronic Pain | Status: UNKNOWN